1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Type I hypersensitivity Global Clinical Trials Review, H2, 2014

Type I hypersensitivity Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Type I hypersensitivity Global Clinical Trials Review, H2, 2014" provides data on the Type I hypersensitivity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type I hypersensitivity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Type I hypersensitivity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Type I hypersensitivity Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 4
Type I Hypersensitivity 4
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Europe 8
Top Countries Contributing to Clinical Trials in North America 9
Clinical Trials by G7 Countries: Proportion of Type I hypersensitivity to Immunology Clinical Trials 10
Clinical Trials by Phase in G7 Countries 11
Clinical Trials in G7 Countries by Trial Status 12
Clinical Trials by Phase 13
Clinical Trials by Trial Status 14
Clinical Trials by End Point Status 15
Unaccomplished Trials of Type I Hypersensitivity 16
Clinical Trials by Sponsor Type 18
Prominent Sponsors 19
Top Companies Participating in Type I hypersensitivity Therapeutics Clinical Trials 20
Clinical Trial Profiles 21
Clinical Trial Overview of Top Companies 21
Allergy Therapeutics plc 21
Clinical Trial Overview of Allergy Therapeutics plc 21
Merck KGaA 23
Clinical Trial Overview of Merck KGaA 23
Clinical Trial Overview of Top Institutes / Government 24
Assistance Publique - Hopitaux de Paris 24
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 24
Five Key Clinical Profiles 25
Appendix 59
Abbreviations 59
Definitions 59
Research Methodology 60
Secondary Research 60
About GlobalData 61
Contact Us 61
Disclaimer 61
Source 61

List of Tables

Type I hypersensitivity Therapeutics, Global, Clinical Trials by Region, 2014* 5
Type I hypersensitivity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 6
Type I hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 7
Type I hypersensitivity Therapeutics Clinical Trials, Europe, Top Countries, 2014* 8
Type I hypersensitivity Therapeutics Clinical Trials, North America, Top Countries, 2014* 9
Proportion of Type I hypersensitivity to Immunology Clinical Trials, G7 Countries (%), 2014* 10
Type I hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 11
Type I hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 12
Type I hypersensitivity Therapeutics, Global, Clinical Trials by Phase, 2014* 13
Type I hypersensitivity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
Type I hypersensitivity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
Type I hypersensitivity Therapeutics, Global, Suspended Clinical Trials, 2014* 16
Type I hypersensitivity Therapeutics, Global, Withdrawn Clinical Trials, 2014* 17
Type I hypersensitivity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 18
Type I hypersensitivity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 19
Type I hypersensitivity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 20
Type I hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergy Therapeutics plc, 2014* 21
Type I hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2014* 23
Type I hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 24

List of Figures

Type I hypersensitivity Therapeutics, Global, Clinical Trials by Region (%), 2014* 5
Type I hypersensitivity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 6
Type I hypersensitivity Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 8
Type I hypersensitivity Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 9
Proportion of Type I hypersensitivity to Immunology Clinical Trials, G7 Countries (%), 2014* 10
Type I hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 11
Type I hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 12
Type I hypersensitivity Therapeutics, Global, Clinical Trials by Phase (%), 2014* 13
Type I hypersensitivity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
Type I hypersensitivity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 18
Type I hypersensitivity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 19
Type I hypersensitivity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 20
GlobalData Methodology 60

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...

Global Clinical Trials Market

Global Clinical Trials Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.